iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance’s development of iTOL-100 towards first in human clinical study for lead program, iTOL-102.
/ Peptomyc S.L., a biotech company specialized in the development of protein therapeutics for cancer treatment, announces that it has received full study approval for its new Phase 1b clinical trial, which will evaluate the combination of the first-in-class MYC
Historic Cowdray Park Polo Club Hosts Both Ladies and Gold Cup Championships
HanchorBio Received IND Approval of HCB101 Multi-Regional Clinical Trial By Taiwan FDA
/ BioGX, a global provider of easy molecular diagnostic solutions, announced accelerated adoption of their high performance Sample-Ready™ PCR assay* for detection of Candida auris, a rapidly spreading, hard to treat fungus with a growing presence in hospitals and long-term
/ On June 27, 2023, Piers Dunhill and the Dunhill Ventures team held a special event at London Climate Action Week in London, with a diverse portfolio of companies that are in the field of health and wellness, biotechnology research,
/ Today, at the margins of the U.S. Africa Financial Inclusion Conference sponsored by the U.S. Trade and Development Agency (USTDA), Brij Technologies, Inc. unveiled Paybills.Africa. The platform seamlessly connects Africa’s merchants globally, allowing customers to settle bills from anywhere
/ Aircraft Engine Lease Finance, Inc. (“AELF”) announced today that it has appointed Philip Scruggs to its Board of Directors. Scruggs brings more than 25 years of experience in the commercial aircraft leasing industry to the US-based leasing and trading
IPO News has just released an upcoming IPO Brochure section on its website. The IPO market has been slow this year but there are still some gems planning on coming to the market. This Private Company research website reports on
/ Today, Dematic announced the global launch of its Noise Reduction Portfolio, a comprehensive solution to address loud work environments across supply chain facilities. The offering includes before and after 3D noise mapping audits throughout a facility, enhanced rollers, slats,
The complete Biomethane process eliminates flares and reduces carbon intensity.
Tournament Benefited the Official Royal Charities of the Prince and Princess of Wales
Extension of Commercial Offtake Agreement through December, 2026; Ocean Partners to Purchase 1M Shares of Common Stock of DynaResource, Inc. at $5 / Share
Extension of Commercial Offtake Agreement through December, 2026; Ocean Partners to Purchase 1M Shares of Common Stock of DynaResource, Inc. at $5 / Share
INNIO’s Jenbacher brand received the COGEN Europe Market Development Award 2023 in recognition of four major projects across the cogeneration sector. – The COGEN Europe event highlighted the latest trends from the energy world in the presence of industry representatives,
/ NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies.
/ The Oligonucleotide Therapeutics Society (OTS) is excited to bring together those in the field of oligonucleotide therapeutics for its 19th Annual Oligo Meeting. Anyone interested in oligonucleotide therapeutics is welcome to join the event, which will be held virtually
Dubai, UAE / LBank, a global digital asset trading platform, is set to embark on an exciting educational initiative to enhance cryptocurrency awareness in key regions worldwide. The ‘LBank Roadshow,’ a series of events, will be held in seven major
Web3: Charting the Internet’s Next Economic and Cultural Frontier explains how the new Web will usher in a new era of possibilities and challenges.
/ IAVI announced today that the first participants have been vaccinated with a Sudan virus (SUDV) vaccine candidate in a first-in-human Phase I clinical trial in the U.S. The IAVI-sponsored trial is funded by the Biomedical Advanced Research and Development